A Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil fumarate (TDF), Each Coformulated with Elvitegravir, Cobicistat, and Emtricitabine...

Arribas, José R.; Thompson, Melanie; Sax, Paul E.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes ., Post Acceptance: March 09, 2017

Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults.

Gallant, Joel E.; Thompson, Melanie; DeJesus, Edwin; More

JAIDS Journal of Acquired Immune Deficiency Syndromes ., Post Acceptance: February 08, 2017

Brief Report: Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results

Gallant, Joel E.; Koenig, Ellen; Andrade-Villanueva, Jaime F.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 69(3):338-340, July 1, 2015.

A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF...

Wohl, David A.; Cohen, Calvin; Gallant, Joel E.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 65(3):e118-e120, March 1, 2014.

A Randomized, Double-blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir DF...

Clumeck, Nathan; Molina, Jean-Michel; Henry, Keith; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 65(3):e121-e124, March 1, 2014.

Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults

Ruane, Peter J.; DeJesus, Edwin; Berger, Daniel; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 63(4):449-455, August 1, 2013.

Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients: Final 5-Year Results From...

Rockstroh, Jürgen K.; DeJesus, Edwin; Lennox, Jeffrey L.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 63(1):77-85, May 1, 2013.

A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil...

Zolopa, Andrew; Sax, Paul E.; DeJesus, Edwin; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 63(1):96-100, May 1, 2013.

A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and...

Rockstroh, Jürgen K.; DeJesus, Edwin; Henry, Keith; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 62(5):483-486, April 15, 2013.

Safety, Efficacy, and Pharmacokinetics of TBR-652, a CCR5/CCR2 Antagonist, in HIV-1–Infected, Treatment-Experienced, CCR5 Antagonist–Naive Subjects

Lalezari, Jacob; Gathe, Joseph; Brinson, Cynthia; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 57(2):118-125, June 1, 2011.

Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses

Lennox, Jeffrey L; DeJesus, Edwin; Berger, Daniel S; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 55(1):39-48, September 1, 2010.

Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral...

DeJesus, Edwin; Young, Benjamin; Morales-Ramirez, Javier O; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 51(2):163-174, June 2009.

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients: 144-Week Analysis

Arribas, Jose R; Pozniak, Anton L; Gallant, Joel E; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 47(1):74-78, January 1, 2008.

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients: Virologic, Immunologic, and...

Pozniak, Anton L; Gallant, Joel E; DeJesus, Edwin; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 43(5):535-540, December 15, 2006.

Antiviral Activity, Pharmacokinetics, and Dose Response of the HIV-1 Integrase Inhibitor GS-9137 (JTK-303) in Treatment-Naive and Treatment-Experienced Patients

DeJesus, Edwin; Berger, Daniel; Markowitz, Martin; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 43(1):1-5, September 2006.

Abacavir and Lamivudine Fixed-Dose Combination Tablet Once Daily Compared With Abacavir and Lamivudine Twice Daily in HIV-Infected Patients Over 48 Weeks (ESS30008, SEAL)

Sosa, Nestor; Hill-Zabala, Christina; DeJesus, Edwin; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 40(4):422-427, December 1, 2005.

Epoetin Alfa Once Weekly Improves Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated With Interferon/Ribavirin: A Randomized Controlled Trial

Sulkowski, Mark S; Dieterich, Douglas T; Bini, Edmund J; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 39(4):504-506, August 1, 2005.

Induction With Abacavir/Lamivudine/Zidovudine Plus Efavirenz for 48 Weeks Followed by 48-Week Maintenance With Abacavir/Lamivudine/Zidovudine Alone in Antiretroviral-Naive...

Markowitz, Martin; Hill-Zabala, Christina; Lang, Joseph; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 39(3):257-264, July 1, 2005.

Abacavir Once or Twice Daily Combined With Once-Daily Lamivudine and Efavirenz for the Treatment of Antiretroviral-Naive HIV-Infected Adults: Results of the Ziagen Once Daily in...

Moyle, Graeme J; DeJesus, Edwin; Cahn, Pedro; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 38(4):417-425, April 1, 2005.